Actual


Orion CMD 2012

Capital Markets Day for analysts, institutional investors and financial media on Thursday 24 May 2012 in Helsinki. Read more here.
 

Orion Group Interim Report Q1/2012

Orion’s net sales for January–March 2012 totalled EUR 247 million (EUR 244 million for January–March 2011), and were at similar level to the comparative period last year. Read more here.
 

Orion's Well-being Lounge renewed

The Well-being Lounge provides reliable health information to people interested in well-being and the pharmaceutical industry, and familiarises visitors with Orion. Read more here.

  

Orion receives European marketing authorisation for dexdor®

 

Orion in collaboration with Plan

As a corporate partner, Orion participates in a Plan project that supports early childhood education in developing countries. The current target country isTimor-Leste (East Timor).

Read more here.




Sustainability Report 2011

The  Sustainability Report for 2011 describes Orion as a corporate citizen. The entire organisation is devoted to ensuring the quality and safety of our products, the most important of our responsibilities. The Report is accessible in the Sustainability section.